COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-10136

  1. 1,026 Posts.
    lightbulb Created with Sketch. 54

    Level: Laboratory Alert

    After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.”

    “CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. ”

    https://www.cdc.gov/csels/dls/locs/...-Changes_CDC_RT-PCR_SARS-CoV-2_Testing_1.html


    none of this would be an issue if there were no issues with PCR picking up influenza.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.